All participants were subjected to detailed clinical history taking, thorough general examination with anthropometric measures (Body weight (BW), Body mass index (BMI), Waist circumference (WC), laboratory testing of complete blood count (CBC), liver function tests
Sotagliflozin, often known as a dual SGLT-1/SGLT-2 inhibitor, has the highest affinity for SGLT1 receptors but is not yet commonly used in diabetic patients as it is the newest SGLT-2is
Among the drug classes under investigation for AD are the glucagon-like peptide-1 receptor agonists (GLP-1RAs), which are approved for the treatment of type 2 diabetes (T2D), obesity and cardiovascular disease
it's about preserving the potential for discovery
Both have shown results in helping people lose weight, but they work in different ways
That was the part no amount of willpower had ever been able to replicate on its own